// Post a message

Replying to:

‘Hard’ Drug Repurposing for Precision Oncology: the Missing Link?

As part of a "research topic" on drug repositioning and metronomic chemotherapy, opened for submission in Fontiers in Pharmacology, Pan Pantziarka, Gauthier Bouche and Nicolas André from the Anticancer Fund, Belgium , The George Pantziarka TP53 Trust, United Kingdom, the Department of Pediatric Hematology-Oncology, Assistance Publique Hôpitaux de Marseille, France and Metronomics Global Health Initiative, France have just publisehd an opinion article entitled : ‘Hard’ Drug Repurposing for (...)


This forum is moderated beforehand: your contribution will only appear after being validated by a site administrator.

Any message or comment?
  • (To create paragraphs, you simply leave blank lines.)

Who are you? (optional)